The Cardiology Core Laboratory for Translational and Clinical Research (CLTCR) was established in 2009. The main function of the CLTCR is to facilitate investigations on clinical outcome and pharmacogenomic research on cardiovascular diseases and to provide resource support for cardiovascular translational and clinical research. Our Core Lab has a well-established infrastructure and standard operating procedure (SOP) for biobanking, and it has become a fundamental resource for establishing and maintaining a variety of cardiovascular biorepositories. These include serum, plasma, DNA, RNA, human heart tissue samples and Induced pluripotent stem cells (iPSC) lines from the Vanderbilt Heart and Vascular Institute (VHVI). Our lab has been the key laboratory for blood and DNA sample processing for cardiovascular clinical trials conducted at the VHVI, and has been the central biorepository for a number of large multi-center clinical trials.
The CLTCR offers experimental services oriented towards development of new biomarkers and detection/identification of genetic mutations/variations for diagnostic test or drug response. These include, but are not limited to, DNA and RNA extractions, SNP detection, real-time RT-PCR on target gene expression, assessment and validation of biomarkers using different platforms, such as ELISA, Luminex technology and Roche Cobas e411. We are committed to developing and applying new technologies for biomarker testing, and to providing our services with the highest quality and integrity.
Resources:
Yan Ru Su, M.D. Kelsey Tomasek Carlos Fulmer Michael Glennon
Director Manager Core Research Asisstant II Core Research Assistant II
Hours | Location |
Monday - Friday, 8AM to 5PM |
332 PRB |
Cardiology Core Lab Gains CAP Accreditation - VUMC Reporter